US Stock MarketDetailed Quotes

MIRM Mirum Pharmaceuticals

Watchlist
  • 43.690
  • +0.270+0.62%
Close May 2 16:00 ET
  • 43.690
  • 0.0000.00%
Post 16:05 ET
2.16BMarket Cap-23.62P/E (TTM)

About Mirum Pharmaceuticals Company

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its products include Maralixibat and Volixibat. The company was founded by Niall O'Donnel, Michael Grey and Christopher Peetz in May 2018 and is headquartered in Foster City, CA.

Company Profile

SymbolMIRM
Company NameMirum Pharmaceuticals
Listing DateJul 18, 2019
Issue Price15.00
Founded2018
CEOMr. Christopher Peetz
MarketNASDAQ
Employees322
Fiscal Year Ends12-31
Address989 East Hillsdale Boulevard,Suite 300
CityFoster City
ProvinceCalifornia
CountryUnited States of America
Zip Code94404
Phone1-650-667-4085
Websitehttp://www.mirumpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Christopher Peetz
  • Director and Chief Executive Officer
  • 6.60M
  • Peter Radovich
  • Chief Operating Officer and President
  • 3.34M
  • Eric H. Bjerkholt, M.B.A.
  • Chief Financial Officer
  • 2.01M
  • Dr. Joanne Quan, M.D.
  • Chief Medical Officer
  • 3.59M
  • Michael Grey
  • Chairman of the Board
  • 408.51K
  • Saira Ramasastry, M.Phil,M.S.
  • Independent Director
  • 368.51K
  • Laura A. Brege
  • Independent Director
  • 383.51K
  • William Carl Fairey, Jr
  • Independent Director
  • 368.51K
  • Timothy P. Walbert
  • Independent Director
  • 363.51K
  • Patrick J. Heron
  • Independent Director
  • 358.51K
  • Dr. Lon Cardon, PhD
  • Independent Director
  • 353.51K
  • Dr. Laurent Fischer, M.D.
  • Independent Director
  • 378.51K

Market Insights

U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Bit Origin
BTOG
0.1893
Riot Platforms
RIOT
8.390
Bitdeer Technologies
BTDR
10.970
4
Argo Blockchain
ARBK
0.4265
5
The9 Ltd
NCTY
12.300
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025